Gentian Diagnostics ASA reported earnings results for the third quarter and nine months ended September 30, 2023. For the third quarter, the company reported sales was NOK 32.07 million compared to NOK 23.07 million a year ago. Revenue was NOK 34.79 million compared to NOK 25.09 million a year ago. Net loss was NOK 0.816 million compared to NOK 9.38 million a year ago. Basic loss per share from continuing operations was NOK 0.05 compared to NOK 0.61 a year ago.
For the nine months, sales was NOK 97.69 million compared to NOK 73.73 million a year ago. Revenue was NOK 104.55 million compared to NOK 81.05 million a year ago. Net loss was NOK 0.565 million compared to NOK 18.99 million a year ago.